Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

The potential of in silico approaches to streamline drug development

The potential of in silico approaches to streamline drug development

BACK

The potential of in silico approaches to streamline drug development

This position paper highlights the potential of in silico medicine, using computational modelling and simulation to aid drug discovery, development, and delivery. It calls for adaptation of in silico technology to be a standard practice to complement in vivo and in vitro approaches in healthcare through a collaborative ecosystem of stakeholders.

The application of in silico methods before animal testing or clinical trials to obtain insights can inform decision making and thus optimise clinical trial design and patient safety. In silico methods have been suggested to complement traditional evidence with digital evidence and therefore to reduce time, cost, and environmental footprint of the regulatory approval process. However, the impact of in silico methods in regulatory decision-making and post-market surveillance remains limited. There is a strong need to develop industrial infrastructure and regulatory framework to actively incorporate CM&Sto foster medical innovation and overcome current socio-economic and technological barriers in the drug development process. We invite all the stakeholders to join arms to promote adequate use of these methods.


Download

NEWS

News Avicenna Day (AAD) 2024 Recordings Now Available

Avicenna Day (AAD) 2024 Recordings Now Available

Did you enjoy AAD 2024 and want to rewatch presentations from world-class thought leaders? Or did you miss the event? This news is for you!

News BioTechX event, Basel

BioTechX event, Basel

The BioTechX event in Basel provided an excellent opportunity for the Avicenna Alliance to engage with key pharmaceutical players and discuss the growing role of in silico methods in drug discovery and development, drug delivery and manufacturing.

News Nobel Prize for in silico modelling

Nobel Prize for in silico modelling

Congratulations to the winners of the 2024 Nobel Prize in Chemistry! This year's prestigious award honours revolutionary advancements in computational modelling, specifically in the study and design of proteins—the fundamental components of life.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2024 Avicenna Alliance | powered by We Berry